Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954692

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954692

Dental Orthobiologics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of dental orthobiologics Market

The global dental orthobiologics market size was valued at USD 1,000.19 million in 2025 and is projected to grow from USD 1,048.06 million in 2026 to USD 1,612.59 million by 2034, exhibiting a CAGR of 5.50% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 48.73% share, driven by high dental implant volumes and strong product innovation.

Dental orthobiologics include natural and synthetic materials designed to promote bone, cartilage, and soft tissue regeneration in dental applications. These products comprise allografts, synthetic bone graft substitutes, demineralized bone matrix, cellular allografts, bone growth factors, and other biologics used in procedures such as dental implants, periodontal regeneration, and jawbone reconstruction.

Market Dynamics

The market is expanding due to the increasing prevalence of dental disorders such as edentulism, periodontal disease, and alveolar bone loss. These conditions frequently require bone grafting and regenerative procedures, thereby driving demand for orthobiologic materials. According to global health reports, oral diseases affect billions of people worldwide, with edentulism showing significant prevalence among aging populations.

The COVID-19 pandemic temporarily reduced market revenues in 2020 as dental clinics restricted services. However, recovery began in 2021 with the reopening of clinics and increased adoption of implant surgeries and bone grafting procedures. The growing use of tele-dentistry and digital treatment planning further supported procedural volumes.

Key Market Trends

A significant trend shaping the dental orthobiologics market is the rapid increase in dental implant procedures. Bone graft substitutes are widely used to enhance jawbone volume and ensure implant stability when natural bone is insufficient. Technological advancements in implantology have increased procedural complexity, further boosting the need for advanced regenerative materials.

Another emerging trend is the growing adoption of synthetic and 3D-printed bone graft substitutes. These products offer improved biocompatibility, predictable regeneration outcomes, and cost efficiency compared to traditional grafts. Innovations in biomaterials are enabling more customized solutions for complex dental surgeries.

Growth Drivers

The rising prevalence of dental bone disorders is a primary growth driver. Periodontal disease, tooth loss, and jawbone atrophy require regenerative procedures supported by orthobiologic materials. Increasing awareness among clinicians about advanced regenerative solutions is also accelerating adoption.

Additionally, the growing use of synthetic bone substitutes is fueling market growth. These materials reduce the risk of immune reactions and disease transmission while offering improved osteoconductive properties. Their affordability and ease of availability further enhance adoption across emerging markets.

Strategic acquisitions and collaborations among industry players are also strengthening product portfolios and expanding global distribution networks.

Restraining Factors

Despite growth potential, clinical limitations may restrict market expansion. Some orthobiologic products are associated with adverse tissue reactions, incomplete bone formation, and immunogenic risks. Complications related to bone morphogenetic proteins and xenografts, such as inflammation or graft displacement, may hinder adoption.

Furthermore, concerns regarding mechanical strength, resorption rates, and long surgical times can affect clinician preference and patient outcomes, posing challenges to market growth.

Market Segmentation Analysis

By Product Type

The bone growth factors segment dominated with a 41.31% share in 2026, driven by rising dental implant procedures that require enhanced bone regeneration. Synthetic bone graft substitutes are expected to grow at a higher CAGR due to their biocompatibility, lower production costs, and increasing export collaborations.

By Form

The paste segment held 45.35% of the market share in 2026, supported by strong R&D focus and widespread use of bone growth factors in paste form. The granules segment is projected to grow at a higher CAGR due to superior osteoblast attachment and increasing product launches.

By End-user

The solo practices segment accounted for 60.49% share in 2026, owing to a large number of independent dental clinics and high patient preference. DSO/group practices are anticipated to grow at a faster rate due to consolidation trends and rising procedural volumes.

Regional Insights

North America generated USD 487.37 million in 2025, maintaining its leadership due to advanced healthcare infrastructure and frequent product launches.

Europe represents the second-largest market, supported by strong players such as Institut Straumann AG and Geistlich Pharma AG.

Asia Pacific is projected to grow at the highest CAGR, driven by rising dental disease prevalence, increasing healthcare spending, and growing penetration of advanced products in Japan, China, and India.

Latin America and the Middle East & Africa are expected to witness steady growth due to rising awareness and healthcare investments.

Key Industry Players

Leading companies include ZimVie Inc., Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, Medtronic, BioHorizons, NovaBone, and Geistlich Pharma AG. Strategic acquisitions, product launches, and geographic expansions are central to maintaining competitive advantage.

Conclusion

The global dental orthobiologics market is set for steady expansion, increasing from USD 1,000.19 million in 2025 to USD 1,612.59 million by 2034, at a CAGR of 5.50%. Growth is driven by rising dental implant procedures, increasing prevalence of bone disorders, and advancements in synthetic graft technologies. Although clinical limitations pose challenges, continuous innovation, strategic collaborations, and expanding dental care infrastructure are expected to sustain long-term market growth worldwide.

Segmentation By Product Type

  • Allograft
  • Synthetic Bone Graft Substitutes
  • Demineralized Bone Matrix
  • Cellular Allografts
  • Bone Growth Factors
  • Others

By Form

  • Paste
  • Granules
  • Putty
  • Others

By End-user

  • Solo Practices
  • DSO/ Group Practices
  • Others

North America (By Product Type, Form, End-user, Country)

    • U.S.
    • Canada
  • Europe (By Product Type, Form, End-user, Country/ Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Form, End-user, Country/ Sub-region)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Form, End-user, Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Form, End-user, Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Product Code: FBI110353

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Dental Disorders, By Key Countries/ Region, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. New Product Launches, By Key Players
  • 4.4. Impact of COVID-19 on the Market

5. Global Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Allograft
    • 5.1.2. Bone Growth Factors
    • 5.1.3. Synthetic Bone Graft Substitute
    • 5.1.4. Demineralized Bone Matrix
    • 5.1.5. Cellular Allografts
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Form
    • 5.2.1. Paste
    • 5.2.2. Granules
    • 5.2.3. Putty
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Solo Practices
    • 5.3.2. DSO/Group Practices
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Allograft
    • 6.1.2. Bone Growth Factors
    • 6.1.3. Synthetic Bone Graft Substitute
    • 6.1.4. Demineralized Bone Matrix
    • 6.1.5. Cellular Allografts
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Form
    • 6.2.1. Paste
    • 6.2.2. Granules
    • 6.2.3. Putty
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Solo Practices
    • 6.3.2. DSO/Group Practices
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Allograft
    • 7.1.2. Bone Growth Factors
    • 7.1.3. Synthetic Bone Graft Substitute
    • 7.1.4. Demineralized Bone Matrix
    • 7.1.5. Cellular Allografts
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Form
    • 7.2.1. Paste
    • 7.2.2. Granules
    • 7.2.3. Putty
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Solo Practices
    • 7.3.2. DSO/Group Practices
    • 7.3.3. Others

8. Market Analysis, Insights and Forecast - By Country/ Sub-Region

  • 8.1.
    • 8.1.1. U.K.
    • 8.1.2. Germany
    • 8.1.3. France
    • 8.1.4. Spain
    • 8.1.5. Italy
    • 8.1.6. Scandinavia
    • 8.1.7. Rest of Europe

9. Asia Pacific Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Allograft
    • 9.1.2. Bone Growth Factors
    • 9.1.3. Synthetic Bone Graft Substitute
    • 9.1.4. Demineralized Bone Matrix
    • 9.1.5. Cellular Allografts
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Form
    • 9.2.1. Paste
    • 9.2.2. Granules
    • 9.2.3. Putty
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Solo Practices
    • 9.3.2. DSO/Group Practices
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Southeast Asia
    • 9.4.6. South Korea
    • 9.4.7. Rest of Asia Pacific

10. Latin America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Allograft
    • 10.1.2. Bone Growth Factors
    • 10.1.3. Synthetic Bone Graft Substitute
    • 10.1.4. Demineralized Bone Matrix
    • 10.1.5. Cellular Allografts
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Form
    • 10.2.1. Paste
    • 10.2.2. Granules
    • 10.2.3. Putty
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Solo Practices
    • 10.3.2. DSO/Group Practices
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America

11. Middle East & Africa Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 11.1. Market Analysis, Insights and Forecast - By Product Type
    • 11.1.1. Allograft
    • 11.1.2. Bone Growth Factors
    • 11.1.3. Synthetic Bone Graft Substitute
    • 11.1.4. Demineralized Bone Matrix
    • 11.1.5. Cellular Allografts
    • 11.1.6. Others
  • 11.2. Market Analysis, Insights and Forecast - By Form
    • 11.2.1. Paste
    • 11.2.2. Granules
    • 11.2.3. Putty
    • 11.2.4. Others
  • 11.3. Market Analysis, Insights and Forecast - By End-user
    • 11.3.1. Solo Practices
    • 11.3.2. DSO/Group Practices
    • 11.3.3. Others
  • 11.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 11.4.1. GCC
    • 11.4.2. South Africa
    • 11.4.3. Rest of Middle East & Africa

12. Competitive Analysis

  • 12.1. Global Market Share Analysis (2025)
  • 12.2. Company Profiles
    • 12.2.1. ZimVie Inc.
      • 12.2.1.1. Overview
      • 12.2.1.2. Products & services
      • 12.2.1.3. SWOT Analysis
      • 12.2.1.4. Recent Developments
      • 12.2.1.5. Strategies
      • 12.2.1.6. Financials (Based on Availability)
    • 12.2.2. Institut Straumann AG
      • 12.2.2.1. Overview
      • 12.2.2.2. Products & services
      • 12.2.2.3. SWOT Analysis
      • 12.2.2.4. Recent Developments
      • 12.2.2.5. Strategies
      • 12.2.2.6. Financials (Based on Availability)
    • 12.2.3. Envista
      • 12.2.3.1. Overview
      • 12.2.3.2. Products & services
      • 12.2.3.3. SWOT Analysis
      • 12.2.3.4. Recent Developments
      • 12.2.3.5. Strategies
      • 12.2.3.6. Financials (Based on Availability)
    • 12.2.4. Dentsply Sirona.
      • 12.2.4.1. Overview
      • 12.2.4.2. Products & services
      • 12.2.4.3. SWOT Analysis
      • 12.2.4.4. Recent Developments
      • 12.2.4.5. Strategies
      • 12.2.4.6. Financials (Based on Availability)
    • 12.2.5. Henry Schein, Inc.
      • 12.2.5.1. Overview
      • 12.2.5.2. Products & services
      • 12.2.5.3. SWOT Analysis
      • 12.2.5.4. Recent Developments
      • 12.2.5.5. Strategies
      • 12.2.5.6. Financials (Based on Availability)
    • 12.2.6. Medtronic
      • 12.2.6.1. Overview
      • 12.2.6.2. Products & services
      • 12.2.6.3. SWOT Analysis
      • 12.2.6.4. Recent Developments
      • 12.2.6.5. Strategies
      • 12.2.6.6. Financials (Based on Availability)
    • 12.2.7. BioHorizons
      • 12.2.7.1. Overview
      • 12.2.7.2. Products & services
      • 12.2.7.3. SWOT Analysis
      • 12.2.7.4. Recent Developments
      • 12.2.7.5. Strategies
      • 12.2.7.6. Financials (Based on Availability)
    • 12.2.8. NovaBone (Halma)
      • 12.2.8.1. Overview
      • 12.2.8.2. Products & services
      • 12.2.8.3. SWOT Analysis
      • 12.2.8.4. Recent Developments
      • 12.2.8.5. Strategies
      • 12.2.8.6. Financials (Based on Availability)
    • 12.2.9. Geistlich Pharma AG
      • 12.2.9.1. Overview
      • 12.2.9.2. Products & services
      • 12.2.9.3. SWOT Analysis
      • 12.2.9.4. Recent Developments
      • 12.2.9.5. Strategies
      • 12.2.9.6. Financials (Based on Availability)
Product Code: FBI110353

List of Tables

  • Table 1: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 3: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 6: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 7: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 10: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 11: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 15: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 18: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 19: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 22: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 23: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Dental Orthobiologics Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Dental Orthobiologics Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Dental Orthobiologics Market Value Share (%), by Form, 2025 & 2034
  • Figure 4: Global Dental Orthobiologics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Dental Orthobiologics Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 7: North America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 9: North America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 10: North America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 12: North America Dental Orthobiologics Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Dental Orthobiologics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 15: Europe Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 17: Europe Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 18: Europe Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 25: Asia Pacific Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 26: Asia Pacific Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 31: Latin America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 33: Latin America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 34: Latin America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 41: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 42: Middle East & Africa Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Dental Orthobiologics Market Share (%), By Company, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!